
1.99 Delayed Data As of Jul 05 | ![]() Today’s Change | 1.58 Today|||52-Week Range 8.72 | -36.83% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $30.2M |
Regulus Therapeutics, Inc. 4224 Campus Point Court San Diego California 92121 |
Joseph P. Hagan | President, Chief Executive Officer & Director |
Crispina Calsada | Chief Financial Officer |
Denis Drygin | Chief Scientific Officer |
Christopher Aker | Secretary, Senior Vice President & General Counsel |
Amin Kamel | Vice President-DMPK |